Cargando…

Towards a unified protocol for handling of CSF before β-amyloid measurements

BACKGROUND: Widespread implementation of Alzheimer’s disease biomarkers in routine clinical practice requires the establishment of standard operating procedures for pre-analytical handling of cerebrospinal fluid (CSF). METHODS: Here, CSF collection and storage protocols were optimized for measuremen...

Descripción completa

Detalles Bibliográficos
Autores principales: Janelidze, Shorena, Stomrud, Erik, Brix, Britta, Hansson, Oskar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642586/
https://www.ncbi.nlm.nih.gov/pubmed/31324260
http://dx.doi.org/10.1186/s13195-019-0517-9
_version_ 1783437006796226560
author Janelidze, Shorena
Stomrud, Erik
Brix, Britta
Hansson, Oskar
author_facet Janelidze, Shorena
Stomrud, Erik
Brix, Britta
Hansson, Oskar
author_sort Janelidze, Shorena
collection PubMed
description BACKGROUND: Widespread implementation of Alzheimer’s disease biomarkers in routine clinical practice requires the establishment of standard operating procedures for pre-analytical handling of cerebrospinal fluid (CSF). METHODS: Here, CSF collection and storage protocols were optimized for measurements of β-amyloid (Aβ). We investigated the effects of (1) storage temperature, (2) storage time, (3) centrifugation, (4) sample mixing, (5) blood contamination, and (6) collection gradient on CSF levels of Aβ. For each study participant, we used fresh CSF directly collected into a protein low binding (LoB) tube that was analyzed within hours after lumbar puncture (LP) as standard of truth. Aβ42 and Aβ40 were measured in de-identified CSF samples using EUROIMMUN and Mesoscale discovery assays. RESULTS: CSF Aβ42 and Aβ40 were stable for at least 72 h at room temperature (RT), 1 week at 4 °C, and 2 weeks at − 20 °C and − 80 °C. Centrifugation of non-blood-contaminated CSF or mixing of samples before the analysis did not affect Aβ levels. Addition of 0.1–10% blood to CSF that was stored at RT without centrifugation led to a dose- and time-dependent decrease in Aβ42 and Aβ40, while Aβ42/Aβ40 did not change. The effects of blood contamination were mitigated by centrifugation and/or storage at 4 °C or − 20 °C. Aβ levels did not differ between the first to fourth 5-ml portions of CSF. CONCLUSIONS: CSF can be stored for up to 72 h at RT, 1 week at 4 °C, or at least 2 weeks at either − 20 °C or − 80 °C before Aβ measurements. Centrifugation of fresh non-blood-contaminated CSF after LP, or mixing before analysis, is not required. In case of visible blood contamination, centrifugation and storage at 4 °C or − 20 °C is recommended. After discarding the first 2 ml, any portion of up to 20 ml of CSF is suitable for Aβ analysis. These findings will be important for the development of a clinical routine protocol for pre-analytical handling of CSF. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13195-019-0517-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6642586
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66425862019-07-29 Towards a unified protocol for handling of CSF before β-amyloid measurements Janelidze, Shorena Stomrud, Erik Brix, Britta Hansson, Oskar Alzheimers Res Ther Research BACKGROUND: Widespread implementation of Alzheimer’s disease biomarkers in routine clinical practice requires the establishment of standard operating procedures for pre-analytical handling of cerebrospinal fluid (CSF). METHODS: Here, CSF collection and storage protocols were optimized for measurements of β-amyloid (Aβ). We investigated the effects of (1) storage temperature, (2) storage time, (3) centrifugation, (4) sample mixing, (5) blood contamination, and (6) collection gradient on CSF levels of Aβ. For each study participant, we used fresh CSF directly collected into a protein low binding (LoB) tube that was analyzed within hours after lumbar puncture (LP) as standard of truth. Aβ42 and Aβ40 were measured in de-identified CSF samples using EUROIMMUN and Mesoscale discovery assays. RESULTS: CSF Aβ42 and Aβ40 were stable for at least 72 h at room temperature (RT), 1 week at 4 °C, and 2 weeks at − 20 °C and − 80 °C. Centrifugation of non-blood-contaminated CSF or mixing of samples before the analysis did not affect Aβ levels. Addition of 0.1–10% blood to CSF that was stored at RT without centrifugation led to a dose- and time-dependent decrease in Aβ42 and Aβ40, while Aβ42/Aβ40 did not change. The effects of blood contamination were mitigated by centrifugation and/or storage at 4 °C or − 20 °C. Aβ levels did not differ between the first to fourth 5-ml portions of CSF. CONCLUSIONS: CSF can be stored for up to 72 h at RT, 1 week at 4 °C, or at least 2 weeks at either − 20 °C or − 80 °C before Aβ measurements. Centrifugation of fresh non-blood-contaminated CSF after LP, or mixing before analysis, is not required. In case of visible blood contamination, centrifugation and storage at 4 °C or − 20 °C is recommended. After discarding the first 2 ml, any portion of up to 20 ml of CSF is suitable for Aβ analysis. These findings will be important for the development of a clinical routine protocol for pre-analytical handling of CSF. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13195-019-0517-9) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-19 /pmc/articles/PMC6642586/ /pubmed/31324260 http://dx.doi.org/10.1186/s13195-019-0517-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Janelidze, Shorena
Stomrud, Erik
Brix, Britta
Hansson, Oskar
Towards a unified protocol for handling of CSF before β-amyloid measurements
title Towards a unified protocol for handling of CSF before β-amyloid measurements
title_full Towards a unified protocol for handling of CSF before β-amyloid measurements
title_fullStr Towards a unified protocol for handling of CSF before β-amyloid measurements
title_full_unstemmed Towards a unified protocol for handling of CSF before β-amyloid measurements
title_short Towards a unified protocol for handling of CSF before β-amyloid measurements
title_sort towards a unified protocol for handling of csf before β-amyloid measurements
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642586/
https://www.ncbi.nlm.nih.gov/pubmed/31324260
http://dx.doi.org/10.1186/s13195-019-0517-9
work_keys_str_mv AT janelidzeshorena towardsaunifiedprotocolforhandlingofcsfbeforebamyloidmeasurements
AT stomruderik towardsaunifiedprotocolforhandlingofcsfbeforebamyloidmeasurements
AT brixbritta towardsaunifiedprotocolforhandlingofcsfbeforebamyloidmeasurements
AT hanssonoskar towardsaunifiedprotocolforhandlingofcsfbeforebamyloidmeasurements